| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 01/02/2002 | CN1329611A Phenylacetic acid heterocyclyl amides having an insecticidal effect |
| 01/02/2002 | CN1329601A New benzimidazolone-benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents |
| 01/02/2002 | CN1329281A Colour photosensitive imaging element containing closed developer |
| 01/02/2002 | CN1329002A Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide |
| 01/01/2002 | US6335460 Treating retroviral infections, including human immunodeficiency virus, and aids |
| 01/01/2002 | US6335445 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 01/01/2002 | US6335334 Hypertensive agents, anticoagulants; cardiovascular and sexual disorders, angina pectoris, and atherosclerosis |
| 12/27/2001 | WO2001098309A1 Process for the preparation of cephem compounds |
| 12/27/2001 | WO2001098276A1 Para-aminophenol derivatives and their use as developers for producing oxidation colorations |
| 12/27/2001 | WO2001098264A1 Macrophage scavenger receptor antagonists |
| 12/27/2001 | WO2001097810A2 Use of therapeutic benzamide derivatives |
| 12/27/2001 | WO2001097808A1 Combinations of depeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabete mellitus |
| 12/27/2001 | WO2001097786A2 Benzothiazole derivatives |
| 12/27/2001 | WO2000064864A9 N-protected amines and their use as prodrugs |
| 12/27/2001 | US20010056189 Pyrazole substituted hydroxamic acid derivatives as cyclooxxgenase-2 and 5- lipoxygenase inhibitors |
| 12/27/2001 | US20010056188 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 12/27/2001 | CA2413299A1 Combinations of dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabetes mellitus |
| 12/26/2001 | CN1328456A Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation |
| 12/26/2001 | CN1327982A Process for preparing 2-chloro-thiazole compound |
| 12/25/2001 | US6333425 Ionic compounds derived from malononitrile in which anionic charge is delocalized; excellent properties of solubility and dissociation |
| 12/25/2001 | US6333323 Indole derivatives with antiviral activity |
| 12/20/2001 | WO2001096874A1 Method for identifying compounds with anti-herpes activity |
| 12/20/2001 | WO2001096333A1 Hetaryl-substituted heterocycles |
| 12/20/2001 | WO2001096323A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096321A1 Process for the preparation of thiazolidinedione derivatives |
| 12/20/2001 | WO2001096305A1 Serine protease inhibitors |
| 12/20/2001 | WO2001095859A2 Novel heterocyclic analogs of diphenylethylene compounds |
| 12/20/2001 | WO2001074788A8 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 12/20/2001 | WO2001040223A3 Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 12/20/2001 | WO2001016108A3 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 12/20/2001 | US20010053851 Antidiabetic agents |
| 12/20/2001 | DE10029077A1 New heterocyclic-substituted thiazole derivatives, useful as total or selective herbicides, insecticides, acaricides, nematocides, ectoparasiticides or antifouling agents |
| 12/20/2001 | CA2412720A1 Method for identifying compounds with anti-herpes activity |
| 12/20/2001 | CA2411805A1 Serine protease inhibitors |
| 12/20/2001 | CA2410171A1 Novel heterocyclic analogs of diphenylethylene compounds and uses thereof |
| 12/19/2001 | EP1164418A2 Color photothermographic elements comprising blocked developing agents |
| 12/19/2001 | EP1163360A2 Composition and device for detecting leukocytes in urine |
| 12/19/2001 | EP1163221A1 Sulfonamide derivatives as 5ht7 receptor antagonists |
| 12/19/2001 | EP1163208A2 Caspase inhibitors and uses thereof |
| 12/19/2001 | EP1163029A2 Nitrate esters and their use for inducing neuroprotection and cognition enhancement |
| 12/19/2001 | CN1327386A Anti-HIV infection agents and method for treating HIV infection |
| 12/19/2001 | CN1326936A Ion liquid |
| 12/19/2001 | CN1076346C Process for producing aromatic or heteroaromatic sulfur compounds |
| 12/18/2001 | USRE37478 1-(arylthioalkyl, arylaminoalkyl, or arylmethylenealkyl)-4-(heteroaryl)piperazines and related compounds useful as antipsychotics and analgesics |
| 12/18/2001 | US6331640 Diaminopropionic acid derivatives |
| 12/18/2001 | US6331633 Antidiabetic agents with no liver toxicity |
| 12/18/2001 | US6331563 N-Hydroxy-2-(Alkyl, Aryl, or Heteroaryl, Sulfanyl, Sulfinyl or Sulfonyl)-3-Substituted Alkyl, Aryl or Heteroarylamides as Matrix Metalloproteinase inhibitors |
| 12/18/2001 | US6331553 Inhibitors of nitric oxide synthase; treating cerebrovascular diseases |
| 12/18/2001 | US6331542 Protease inhibitors |
| 12/13/2001 | WO2001094326A1 Novel thiazolidinedione derivatives and use thereof as drugs |
| 12/13/2001 | WO2001094325A1 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
| 12/13/2001 | WO2001094318A2 Method for synthesis of substituted azole libraries |
| 12/13/2001 | WO2001094317A2 Method for synthesis of substituted azole libraries |
| 12/13/2001 | WO2001094309A1 Drug composition antagonistic to both pgd2/txa2 receptors |
| 12/13/2001 | WO2001094301A2 Factor viia inhibitory (thio)urea derivatives, their preparation and their use |
| 12/13/2001 | WO2001093867A1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors |
| 12/13/2001 | WO2001093802A2 Use of riluzole or its salts for preventing and treating adrenoleukodystrophy |
| 12/13/2001 | WO2001049275A3 Methods and compositions for mitigating pain using nitrate esters |
| 12/13/2001 | WO2001042787A3 Immunoassay for neonicotinyl insecticides |
| 12/13/2001 | WO2001027308A3 13-alkyl epothilone derivatives |
| 12/13/2001 | US20010051731 Para-amine substituted phenylamide glucokinase activators |
| 12/13/2001 | US20010051646 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 12/13/2001 | US20010051645 Thyroid receptor ligands |
| 12/13/2001 | CA2345195A1 Color photothermographic elements comprising blocked developing agents |
| 12/12/2001 | EP1162194A1 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use |
| 12/12/2001 | EP1161423A1 Thiazolyl urea derivatives and their utilization as antiviral agents |
| 12/12/2001 | EP1161417A1 Methods and compositions for treating leukemia |
| 12/12/2001 | EP1161415A2 N-cyanomethylamides as protease inhibitors |
| 12/12/2001 | EP1161233A2 Lxr modulators |
| 12/12/2001 | EP1119546A4 Process for preparing toluenesulfinates |
| 12/12/2001 | EP0874854B1 Cephalosporin antibiotics |
| 12/12/2001 | EP0781126B1 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system |
| 12/12/2001 | EP0732923B1 Pharmaceutical compositions containing HIV protease inhibitors |
| 12/12/2001 | EP0675924B1 Cyclic-substituted unsymmetrical cyanine dyes |
| 12/12/2001 | CN1326449A Chrystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2, 4-thiazolidinedione |
| 12/12/2001 | CN1326442A Pesticides |
| 12/11/2001 | US6329531 For therapy of alzheimer's disease |
| 12/11/2001 | US6329404 Pharmaceutical composition |
| 12/11/2001 | US6329400 Formamide compounds as therapeutic agents |
| 12/11/2001 | US6329374 Non-systemic control of parasites |
| 12/11/2001 | US6329373 Metalloproteinase inhibitors |
| 12/11/2001 | US6329372 Phenylalanine derivatives |
| 12/11/2001 | US6329371 α-substrates benzyl heterocyclic derivatives, intermediates for producing the same and agrochemical composition containing the same as active ingredient |
| 12/06/2001 | WO2001092241A1 Benzamide derivatives and their use as apob-100 and mtp inhibitors |
| 12/06/2001 | WO2001092239A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists |
| 12/06/2001 | WO2001046165A3 N-heteroaryl-amides and their use as parasiticides |
| 12/06/2001 | WO2001036426B1 Pyridinones to treat and prevent bacterial infections |
| 12/06/2001 | WO2000078314A8 Process for making arylthiazolidinedione derivatives |
| 12/06/2001 | US20010049374 Amidino derivatives of quinoline and naphthalene |
| 12/06/2001 | US20010049367 Cyclic and bicyclic diamino histamine-3 receptor antagonists |
| 12/06/2001 | DE10026565A1 Ionische Flüssigkeiten Ionic Liquids |
| 12/06/2001 | CA2409006A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists |
| 12/05/2001 | EP1160249A2 Ionic liquids |
| 12/05/2001 | EP1160236A2 Production of mixed acid anhydride and amine compound |
| 12/05/2001 | EP1159273A1 Compounds useful as reversible inhibitors of cathepsin s |
| 12/05/2001 | EP1159265A1 C-16 unsaturated fp-selective prostaglandins analogs |
| 12/05/2001 | EP1159262A1 Tyrosine alkoxyguanidines as integrin inhibitors |
| 12/05/2001 | EP1045848B1 Process for preparation of 2-aminothiazolecarboxamide derivatives |
| 12/05/2001 | EP0636026B1 Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor |
| 12/05/2001 | CN1325397A 2-piperazino alkylatnino benzoazole derivatives: dopamine receptor subtype sepcific ligands |